"Paper publish year","DOI","Category (Protein Mimetic)","Mimic of which Protein","Name of the Protein mimetic","Functions","Activity"
"2007","https://doi.org/10.2174/156802607779318325","cyclic peptide","extracellular matrix proteins that contain the Arg-Gly-Asp (RGD) sequence","c(RGDfV)","Integrin antagonist : blocks integrin αVβ3 receptor binding","Inhibits angiogenesis : prevents tumor-induced blood vessel formation"
"2007","https://doi.org/10.2174/156802607779318325","cyclic peptide","Disintegrins","ACDCRGDCFCG","acts as an integrin antagonist by blocking the binding of natural ligands to integrin receptors like αVβ3 and αIIbβ3.","It inhibits cell adhesion and migration, disrupting processes such as angiogenesis and tumor progression."
"2007","https://doi.org/10.2174/156802607779318325","peptide ","clic pentapeptide ","diketopiperazine (DKP) ","Mimics peptide structures to support functional side chains.","Acts as an antagonist (specifically for CXCR4)."
"2007","https://doi.org/10.2174/156802607779318325","cyclic peptide","αIIbβ3 integrin receptor","Cyclic RGD-containing disulfide derivative","Antagonist of the αIIbβ3 integrin receptor","Highly active antagonist with extended conformation at Gly residue"
"2007","https://doi.org/10.1039/b710425a","Synthetic backbone scaffold"," α-helices peptides","Terphenyl scaffold","Designed to project sidechain functionality similar to that found in α-helices.","Used as inhibitors of protein–protein interactions"
"2007","https://doi.org/10.1039/b710425a","Peptide mimetic","human parathyroid hormone (hPTH)","Truncated mimetic of human parathyroid hormone (hPTH)","Stabilized by lactam bridges to enhance its biological activity","elivers therapeutic osteogenic agents with high potency."
"2007","https://doi.org/10.1039/b710425a","Peptide mimetic","Respiratory syncytial virus (RSV) protein","Cyclic pentapeptide scaffold","Mimics the α-turns of the RSV protein.","Inhibits fusion of viral and cell membranes, preventing viral entry into cells."
"2007","https://doi.org/10.1039/b710425a","Peptide mimetic"," α-helices peptides","Hydrazone-linked peptides","To stabilize α-helical structures by replacing the N-terminal i and i + 4 hydrogen bond with a covalent link","Forms well-defined short α-helices with minimal perturbations to molecular recognition surfaces."
"2007","https://doi.org/10.1039/b710425a","Synthetic scaffold","Marine toxin-related α-helical structures","Trans-fused tetracyclic ethers","To create a receptor for sequence-selective binding of spaced aspartate pairs on the surface of α-helical peptides.","Intended to disrupt protein–protein interactions and bind larger areas in a cell-permeable manner"
"2007","https://doi.org/10.1039/b710425a","Peptide mimetic"," α-helices peptides","Carbon–Carbon Linked Peptides","Introduces a carbon–carbon bond to stabilize the helical structure.","Results in well-defined short α-helices from sequences that do not spontaneously form helices, with minimal perturbations to their molecular recognition surfaces"
"2007","https://doi.org/10.1039/b710425a","Peptide mimetic","TTTT(Type I antifreeze proteins (AFPs))","15-residue peptide with a single Thr repeat and i, i + 4 lactam bridge","Stabilizes a pyramidal plane on the surface of growing ice crystals.","Shows potential antifreeze activity, but not as effective as TTTT."
"2007","https://doi.org/10.1039/b710425a","Peptide mimetic","TTTT(Type I antifreeze proteins (AFPs))","Ala-rich peptides with spaced Lys residues","Exhibits antifreeze activity.","Weaker antifreeze activity compared to TTTT."
"2007","https://doi.org/10.1152/ajpcell.00097.2007","Connexin mimetic peptide","Cx43","43Gap26","Inhibits gap junction channel formation","Attenuates junctional conductance over time"
"2007","https://doi.org/10.1152/ajpcell.00097.2007","Connexin mimetic peptide","Cx43","43Gap27","Inhibits gap junction channel formation","No acute effect but moderate long-term attenuation of membrane conductance"
"2007","https://doi.org/10.1152/ajpcell.00097.2007","Connexin mimetic peptide","Cx32","32Gap24","Attenuates nonjunctional membrane conductance","No acute effect on membrane conductance"
"2007","https://doi.org/10.1152/ajpcell.00097.2007","Connexin chimera","Cx32 (with sequence from Cx43)","Cx32E143","Forms both gap junction channels and nonjunctional conductance","Provides a model to study Cx32 channels"
"2007","https://doi.org/10.1152/ajpcell.00097.2007","Pannexin mimetic peptide","Pannexin-1","PanxE1b","Mimics extracellular loop sequences of pannexin1","Inhibits pannexin currents by more than 10%."
"2007","https://doi.org/10.1152/ajpcell.00097.2007","Pannexin mimetic peptide","Pannexin-1","10Panx1","Blocks pannexin-1 channel activity","Inhibits pannexin-1 channels; used to study ATP release and intercellular calcium wave propagation"
"2007","https://doi.org/10.1002/anie.200700657","α-helix mimetic","Coactivator LXXLL motif","Biaryl scaffold (with ortho substituent)","Mimics i, i+3, and i+4 residues of an α-helix","Inhibits helix–protein interactions, specifically mimicking LXXLL motif"
"2007","https://doi.org/10.4161/auto.4237","BH3 mimetic","BH3","ABT737","Competitively inhibits the interaction between Beclin 1 and Bcl-2/Bcl-XL, which stimulates autophagy","ABT737 disrupts the inhibitory complex between Beclin 1 and Bcl-2/Bcl-XL, thus promoting autophagy by liberating Beclin 1 from its inhibition"
"2007","https://doi.org/10.1158/0008-5472.CAN-07-5173","Smac mimetic compound","Smac","LBW242","argets inhibitor of apoptosis proteins (IAPs) such as XIAP and cIAP1, leading to the induction of apoptosis in cancer cells","induces apoptosis in cancer cells by activating caspase-8, increasing TNFa expression, and overcoming drug resistance."
"2008","https://doi.org/10.1002/bip.20979","Quaternary Protein Mimetic","gp41","3α -N36","Mimics the fusogenic state of HIV-1 gp41","Elicits neutralizing antibodies against HIV-1, inhibits viral infectivity"
"2008","https://doi.org/10.1002/bip.20979","Peptide mimetic","Amyloid β-peptide (Aβ)","D-[chGly-Tyr-chGly-chGly-mLeu]-NH2","Acts as an indicator for existing mature Aβ fibrils and may be used to screen for peptide-based compounds capable of binding to Aβ fibrils","Binds to Aβ fibrils and initiates fibrillization"
"2008","https://doi.org/10.1002/bip.20979","Peptide mimetic","Amyloid β-peptide (Aβ)","KLVFF","Reduces the toxicity of Aβ to neuronal cells by coassembling with mature Aβ fibrils and soluble oligomers","Binds to Aβ fibrils"
"2008","https://doi.org/10.1002/bip.20979","Peptide mimetic","Amyloid β-peptide (Aβ)","LVFFA","Reduces the toxicity of Aβ to neuronal cells by coassembling with mature Aβ fibrils and soluble oligomers","Binds to Aβ fibrils"
"2008","https://doi.org/10.1002/bip.20979","Peptide mimetic","Amyloid β-peptide (Aβ)","AP13Q","recognizing Aβ and preventing its oligomerization","Binds to Aβ fibrils"
"2008","https://doi.org/10.1002/bip.20979","Peptide mimetic","Amyloid β-peptide (Aβ)","P13H","Reduces the toxicity of Aβ to neuronal cells","Inhibits Aβ oligomerization"
"2008","https://doi.org/10.1016/j.drudis.2008.07.008","protein epitope mimetic ","Protegrin I","IB367 (Iseganan)","in clinical trials for the treat- ment of oral mucositis","antimicrobial activity and a considerably reduced hemolytic activ- ity on red blood cells"
"2008","https://doi.org/10.1016/j.cbpa.2008.09.023","binding site mimetic","gp120","Synthetic CD4-binding site mimetic","Designed to mimic the CD4-binding site of gp120","Antibodies raised against this mimetic recognize the gp120, compete with the broadly neutralizing antibody mAb b12, whose epitope overlaps the CD4-binding site, for binding to gp120"
"2008","https://doi.org/10.1042/BST0361414","proteomimetic inhibitors","smMLCK (smooth muscle myosin light-chain kinase)","The terphenyl scaffold","Disrupts protein–protein interactions","binds to calmodulin using an α-helical domain"
"2008","https://doi.org/10.2174/187152708783885174","Peptidomimetic","pharmacophores of mAb 5C3 and NGF peptide analogues","D3","Neuroprotective agent","proteolytically stable agonist of the TrkA receptor, can activate a tyrosine kinase neurotrophin receptor that normally binds a relatively large protein ligand"
"2008","https://doi.org/10.2174/187152708783885174","Peptidomimetic","pharmacophores of mAb 5C3 and NGF peptide analogues","C59","-","Lacked neurotrophic effects"
"2008","https://doi.org/10.2174/187152708783885174","Cyclic peptide","N-cadherin","N-Ac-CHAVDINGHAVDICNH2 (SW4)","Promotes survival of primary CNS neurons","It functions by binding to and clustering N-cadherin in neurons, activating an N-cadherin/FGF signaling cascade, which is neuroprotective."
"2008","https://doi.org/10.2174/187152708783885174","NCAM mimetic peptide","NCAM (Neural Cell Adhesion Molecule)","C3 (C3d)","Induces neurite outgrowth and promotes survival of neurons","Binds to NCAM IgI module, mimics NCAM homophilic binding, promotes CNS neuron survival, and neurite outgrowth"
"2009","https://doi.org/10.1021/ja810025g","α-helix mimetic","MDM2 (Mouse Double Minute 2 homolog) in its interaction with p53 (Tumor Protein p53)","H₂N-Phe-[Trp]-Leu-OH","designed to inhibit the binding of MDM2 to p53, which is crucial for regulating the cell cycle and preventing tumor formation.","identified as a lead inhibitor with effective activity against MDM2/p53 binding, demonstrating a significant inhibitory effect (IC₅₀ < 50 μM)"
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","18A","Mimics the amphipathic helix of ApoA-I","contained 18 amino acids and formed a class A amphipathic helix."
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","2F","stability and lipid-binding properties were improved","mimicked many of the lipid binding properties of apoA-I but failed to alter lesions in a mouse model of atherosclerosis."
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","4F","Inhibits inflammation and improves HDL properties","Administered as D-amino acid (D-4F) reduced atherosclerotic lesions in LDL receptor–null and apoE-null mice without altering plasma cholesterol levels. Improved anti-inflammatory properties in various conditions."
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","5F","Protects against atherosclerosis","L-5F significantly protected mice from diet-induced atherosclerosis and improved HDL's anti-inflammatory properties."
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","3F14","did not reduce lesion area in apoE-null mice.","Ineffective in scavenging lipid hydroperoxides; did not reduce lesion area in apoE-null mice."
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","3F-2","gnificantly reduced lesion area in apoE-null mice","gnificantly reduced lesion area in apoE-null mice"
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","4F-P-4F","Enhances HDL remodeling","Associated with all lipoprotein classes; improved HDL remodeling and cholesterol efflux, but not effective against LDL oxidation compared to single 4F peptide."
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","apoE","Ac-hE-18A-NH2","reduces plasma cholesterol levels in WHHL rabbits and improves arterial endothelial function.","Changes are associated with reduced plasma lipid hydroperoxide levels, an increase in paraoxonase-1 activity, and a reduction of superoxide anion levels."
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","37pA","could be used to construct nanoparticles for delivering MRI contrast agent into arteries to elucidate atherosclerotic plaque composition in a mouse model of atherosclerosis.","contrast for the detection of atherosclerotic macrophages even though the larger peptide demonstrated better lipid-binding properties"
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","L-4F","ability to resist enzymatic degradation","inhibit atherosclerotic lesions , binds niclosamide forming a very tight association that protects the peptide from trypsin digestion allowing L-4F absorption and biological activity after oral administration"
"2009","https://doi.org/10.1161/ATVBAHA.109.187518","Peptide Mimetic","ApoA-I","D-4F","ability to resist enzymatic degradation","inhibit atherosclerotic lesions."
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Peptides","Smac","4–8 N-terminal residues of Smac","targets MCF-7 breast cancer cells","combines with Paclitaxel, etoposide, SN-38,\nor doxorubicin"
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Peptides","Smac","4 or 7 N-terminal residues of Smac","targets  Human acute leukemia Jurkat T cells","combines with Epothilone B derivative\n(BMS 247550) or Apo-2L/TRAIL"
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Peptides","Smac","6 N-terminal residues of Smac","targets  HeLa cervical cancer cells",""
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Peptides","Smac","7 N-terminal residues of Smac","targets  L428 and L540 human Hodgkin lymphoma cells","combines with Granzyme B"
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Peptides","Smac","7 N-terminal residues of Smac with antenopedia sequence","targets Caki-1 renal carcinoma cells","combines with None or cisplatin"
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Peptides","Smac","7 N-terminal residues of Smac conjugated to 8 arginine residues","targets Suit-2, CFPAC-1, Panc1, and BxPC-3 pancreatic cancer cells (a) H460 non-small-cell lung cancer, (b) H460 xenograft mouse model","combines with (a) Cisplatin or taxol, (b) cisplatin"
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Peptides","Smac","7 N-terminal residues of Smac conjugated to the protein transduction domain of TAT protein","targets (a) SHEP/Bcl-2 neuroblastoma, SH-SY5Y\nneuroblastoma, Mel-HO melanoma, Panc1\npancreatic carcinoma, (b) U87 MG human\nmalignant glioma xenograft mouse model","combines with (a) TRAIL or doxorubicin, (b) TRAIL"
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Polynucleotides","Smac","Flag-C-tagged mature Smac pcDNA3.1","targets K562 and CEM human leukaemic cells","combines with Ultraviolet light or TRAIL"
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Polynucleotides","Smac","Flag-C-tagged full-length Smac","targets NC65 and Caki-1 renal carcinoma cells","combines with TRAIL or cisplatin"
"2009","https://doi.org/10.1097/CAD.0b013e32832ced78","Polynucleotides","Smac","pcDNA3.1","targets Human acute leukemia Jurkat T cells","combines with Epothilone B derivative (BMS 247550) or Apo-2L/TRAIL"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","Recombinant protein mimetic","Silk and elastin","Silk-Elastin-Like Protein (SELP)","Gene delivery","Prolonged and localized expression of adenoviruses for up to 15 days"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","Triblock copolymer","Elastin","LysB10","Mechanical responses,  limited local inflammatory activity and displayed relatively thin fibrous capsules.\n","Enhanced elastic modulus, reduced creep strain"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","Triblock copolymer","Elastin","R4","Mechanical responses,  limited local inflammatory activity and displayed relatively thin fibrous capsules.\n","Enhanced elastic modulus, reduced creep strain"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","homopolymers or copolymers","Elastin","VPGVG","Mimics the natural flexibility and biocompatibility of elastin for implant-related applications","Does not induce significant inflammatory or allergic reactions; not recognized as an antigenic epitope of elastin"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","homopolymers or copolymers","Elastin","VPGKG","Mimics elastin’s properties, particularly in relation to implant biocompatibility","No significant inflammatory or allergic response reported"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","homopolymers or copolymers","Elastin","VPGEG","Used for implant-related applications, mimicking elastin's characteristics","No significant inflammatory response observed"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","homopolymers or copolymers","Elastin","IPAVG","Mimics the biological properties of elastin in implant contexts","Does not cause significant inflammatory reactions"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","homopolymers or copolymers","Elastin","VPAVG","Elastin mimetic, used for subcutaneous and intravitreal injections","No inflammatory response observed after 28 days"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","homopolymers or copolymers","Elastin","Chemically synthesized poly(GVGVP)","Mimics the structural and functional properties of elastin, used in various implant routes (intravenous, intraocular, intramuscular, etc.)","Did not induce toxicity; no immune response, but a fibrous capsule was noted after intramuscular implantation"
"2009","https://doi.org/10.1016/j.biomaterials.2008.09.040","homopolymers or copolymers","Elastin","Chemically synthesized poly(VPAVG)","Mimics elastin for implant and injection applications (subcutaneous and intravitreal)","No inflammatory response observed after 28 days, though retinal detachment was noted in some cases"
"2009"," https://doi.org/10.1007/s11883-009-0008-8","peptide","Apolipoprotein A-I (apoA-I)","4F Peptides","Increases formation of pre-β HDL; enhances cholesterol efflux; reduces lipoprotein oxidation; improves antioxidants and vascular repair; reduces renal inflammation","Improves vasodilation, oxidative stress, myocardial inflammation, and angiogenic potential in various models; reduces adiposity and improves insulin sensitivity in obese mice; improves HDL inflammatory properties in humans with coronary heart disease"
"2009","https://doi.org/10.1002/bip.21164","Cyclic ligand-mimetic","Arg-Gly-Asp (RGD) peptide","Cilengitide","Binds to and inhibits avβ3 and avβ5 integrins, inhibiting endothelial interactions and angiogenesis","Currently in clinical trials for the treatment of glioblastoma"
"2009","https://doi.org/10.1080/15419060801891034","Cx-mimetic peptides","Cx43","Gap 27/43","Inhibits CxHc within minutes and gap junctions,  may be useful in reducing damage after spinal cord injury.","inhibiting intercellular communication and antigen cross presentation in dendritic cells, T-cell activation and production of immunoglobulins and cytokines in mixed lymphocyte cultures"
"2009","https://doi.org/10.1080/15419060801891034","Cx-mimetic peptides","Cx43","Gap 27/40","Inhibits Cx40 gap junctions,  may be useful in reducing damage after spinal cord injury.","inhibiting intercellular communication and antigen cross presentation in dendritic cells, T-cell activation and production of immunoglobulins and cytokines in mixed lymphocyte cultures"
"2009","https://doi.org/10.1146/annurev.med.60.042307.181154","peptide mimetic","TPO","Romiplostim","bind to and activate the TPO receptor, mimicking natural TPO and stimulating platelet production in the bone marrow. Dimerization of these mimetics enhances receptor activation.","increase platelet production, have a long half-life (120–160 hours), and reduce the risk of immunogenicity by lacking homology with endogenous TPO."
"2009","https://doi.org/10.1146/annurev.med.60.042307.181154","Non peptide","TPO","Eltrombopag","ffectively increasing platelet counts in patients with conditions such as immune thrombocytopenic purpura (ITP) and other forms of thrombocytopenia.","specifically binds to the transmembrane domain of the TPO receptor, activating it to stimulate megakaryocyte proliferation and platelet production"
"2009","https://doi.org/10.1080/15419060801891018","peptide","Connexin","Gap24","mimics Connexin ","applied at 200 µM did not affect Cx32E143 channels but reversibly inhibited Panx1 channels, Carboxyfluorescein uptake\nby Cx32E143-expressing oocytes was unaffected by it"
"2009","https://doi.org/10.1080/15419060801891018","peptide","Connexin","Gap26","mimics Connexin ","Inhibition of gap junction channel formation: Cx32E143 +   "
"2009","https://doi.org/10.1080/15419060801891018","peptide","Connexin","Gap27","mimics Connexin ","Inhibition of gap junction channel formation: Cx43 +   "
"2009","https://doi.org/10.1080/15419060801891018","peptide","pannexin","Panx1","“pseudospecificity”, the effect of the Panx1 peptide, like that of the connexinmimetic peptides, ","inhibited Cx46 connexon currents, Carboxyfluorescein uptake\nby Cx32E143-expressing oocytes was unaffected by it"
"2010","https://doi.org/10.1126/science.1182749","Peptidomimetic Antibiotics","PG1","L27-11","spectrum of antimicrobial activity, including minimal inhibitory concentrations (MICs) in the nanomolar range against many Pseudomonas aeruginosa (PA) strains and other Pseudomonas spp.","weakly active or inactive against other Grampositive and Gram-negative bacteria"
"2010","https://doi.org/10.1126/science.1182749","Peptidomimetic Antibiotics","PG1","L26-19","No fluorescence increase was apparent over 120 min when PA cells were exposed to it","no notable lysis of human red blood cells at concentrations up to 100 mg/ml"
"2010","https://doi.org/10.1134/S160767291005011X","dipeptide mimetics","NGF","GK-1","exhibited neuroprotective activity in the concentration range 10–5 to 10–9 M","at a concentration of 10–5 M attenuated the differentiating effect of NGF by 50%, exhibited the properties\nof a tyrosine kinase receptor antagonist"
"2010","https://doi.org/10.1134/S160767291005011X","dipeptide mimetics","NGF","GK-2","reduced the viability of neurons and suppressed the neuroprotective effect of GK2 and NGF","GK2 at a concentration of 10–8 M increased the content of pTrkA, exhibited the properties\nof a tyrosine kinase receptor agonist"
"2010","https://doi.org/10.1134/S160767291005011X","dipeptide mimetics","NGF","GK-5","exhibited slight neuroprotective activity; however, they exerted differenti ating properties (caused elongation of PC12 cells and development of outgrowths on them)","increased the amount of heat shock proteins"
"2010","https://doi.org/10.1134/S160767291005011X","dipeptide mimetics","NGF","GK-6","exhibited slight neuroprotective activity; however, they exerted differenti ating properties (caused elongation of PC12 cells and development of outgrowths on them)","increased the amount of heat shock proteins"
"2010","https://doi.org/10.1016/j.addr.2010.04.007","elastin-mimetic triblock copolymer","elastin","B9","Drug delivery","Monodisperse size distribution, spherical shape"
"2010","https://doi.org/10.1016/j.addr.2010.04.007","elastin-mimetic triblock copolymer","elastin","B10","Designed for drug delivery and biomedical applications","Gel forming temperature is 5 degrees lower than B9  ,Exhibits viscoelastic properties with lower tan δ, indicating a more stable gel structure - Mechanical properties can be tuned through changes in midblock and endblock sizes"
"2010","https://doi.org/10.1016/j.addr.2010.04.007","elastin-mimetic triblock copolymer","elastin","C5","Designed for biomedical applications","Gel forming temperature is 14.8 °C <br> - Exhibits lower viscosity compared to B9 <br> - Rheological behavior indicates less viscoelasticity compared to B9"
"2010","https://doi.org/10.1016/j.addr.2010.04.007","elastin-mimetic triblock copolymer","elastin","LysB10","Designed for drug delivery and biomedical applications","Exhibits elastomeric behavior when chemically cross-linked <br> - Designed for enhanced mechanical properties and potential for drug delivery"
"2010","https://doi.org/10.1016/j.addr.2010.04.007","elastin-mimetic triblock copolymer","elastin","R4","Designed for drug delivery and biomedical applications","Exhibits significantly different viscoelastic properties compared to LysB10 due to the more hydrophobic nature of the midblock <br> - Higher tan δ and complex viscosity indicate greater viscoelasticity, making it suitable for specific biomedical applications"
"2010","https://doi.org/10.1016/j.biomaterials.2010.02.019","biomimetic ","resilin","rec1-resilin","transformation from globule to coil to extended coil\nconformation, thus applications in many areas including biotechnology, medicine, sensors, controlled drug delivery systems and engineering","binding ability of rec1-resilin on a substrate is strongly pH-dependent the protein, adsorbed onto the gold substrate with different orientation depending on pH, such as back-on adsorption at acidic pH of 2, compact end-on bilayer adsorption at the IEP and side-on at high alkaline pH of 12"
"2010","https://doi.org/10.1002/jbm.a.32979","peptide","Collagen","Gly-Phe-Hyp-GlyGlu-Arg (GFOGER","major recognition site for α2β1 integrin binding, promoting robust integrin-mediated cell adhesion, osteoblastic differentiation, and bone repair","promotes α2β1 integrin-mediated cell adhesion, osteoblastic differentiation, and enhances bone repair and implant integration"
"2010","https://doi.org/10.1002/jbm.a.32979","peptide","Collagen","DGEA","a2b1 recognition sequence in type I c,1 although a\ndifferent study failed ","inhibits the osteoblastic phenotype of rat bone marrow stromal cells cultured on type I collagen. DGEA-coated hydroxyapatite disks have promoted cell adhesion and upregulated osteoblast marker expression in mesenchymal stem cells in vitro."
"2010","https://doi.org/10.1002/jbm.a.32979","peptide","Collagen","P15","enhances cell adhesion, osteoblastic gene expression, and mineralization on anorganic bone matrix (ABM) in vitro and accelerates early bone formation in porcine and rat cranial defects","improved new bone formation wen implanted into rat tibiae, P15 peptide-coated ABM has also been used in\nhuman periodontal osseous defects resulting in better\nclinical outcomes than open flap debridement alone and has\nalso been used in a pilot clinical study for long-bone\ndefects"
"2010","https://doi.org/10.1073/pnas.1004261107","soluble trimeric peptide mimetic","NHR region of the prehairpin intermediate- gp41","IQN17","mimicks NHR\nregion of the prehairpin intermediate","NHR-binding inhibitors of HIV-1 infection using mirror image phage display, providing strong evidence that IQN17 presents the NHR region in the same structure as is present in the actual prehairpin intermediate"
"2010","https://doi.org/10.1073/pnas.1004261107","chimeric","gp41","IZN17","Immunogen","dependent on self-association"
"2010","https://doi.org/10.1073/pnas.1004261107","Peptide","gp41","(CCIZN17)3","peptide is potentially a better immunogen than IZN17, ","trimeric state of the peptide is not dependent on self-association as for IZN17, and the conformational epitope within the hydrophobic pocket is therefore expected to be present even at the highly diluted concentrations resulting from vaccination"
"2010","https://doi.org/10.1073/pnas.1004261107","Peptide","gp41","(CCIPN17)3","to shield the IZ scaffold from immune recognition in an attempt to minimize generation of antibodies against the nonrelevant portion of the peptide chimera, and subsequently focus the immune response against the NHR region. T","binds D5 with an efficiency similar to (CCIZN17)3"
"2010","https://doi.org/10.1073/pnas.1004261107","Peptide","gp41","(CCIZN36)3","Peptide mimetics of a longer segment of the NHR","elicit neutralizing antibody responses that can be detected in unfractionated serum from guinea pigs. T"
"2010","https://doi.org/10.1073/pnas.1004261107","Peptide","gp41","(CCIPN36)3","Peptide mimetics of a longer segment of the NHR","elicit neutralizing antibody responses that can be detected in unfractionated serum from guinea pigs. T"
"2011","https://doi.org/10.1016/j.bbamem.2011.03.016","Membrane protein mimetic","arious Membrane Proteins (MPs), including integrin β3, transmembrane segments, and apoptotic protein BNip3.","bichelles ","Bicelles mimic membrane environments for studying membrane proteins",""
"2011","https://doi.org/10.1016/j.bbamem.2011.03.016","Membrane protein mimetic","Cytochrome P450, rhodopsin, voltage-sensing domain of KvAP","Nanodiscs","Reconstitute membrane proteins in a functional form within a stable and flat lipid bilayer","Facilitate NMR studies of membrane proteins by providing a more native-like environment compared to micelles, with stable and tunable size for better structural and functional analysis."
"2011","https://doi.org/10.1016/j.bbamem.2011.03.016","Membrane protein mimetic","Mitochondrial complex I, human GPCRs (BLT1 and BLT2), bacterial outer membrane proteins (OmpA and OmpX), bacteriorhodopsin, SR calcium ATPase, nicotinic acetylcholine receptor","Amphipols","Short amphipathic polymers that stabilize membrane proteins in aqueous solutions without disrupting their structure.","Maintains protein solubility and activity, facilitating NMR studies with improved folding yields compared to detergents."
"2011","https://doi.org/10.1016/j.bbamem.2011.03.016","Membrane protein mimetic","Potassium channel KcsA, lipid-anchored proteins (e.g., recoverin, HIV-1 matrix protein)","Reverse Micelles","Encapsulates proteins in a non-polar environment while retaining hydration.","Used for studying proteins that require a low-viscosity environment, although they may not fully replicate native conditions."
"2011","https://doi.org/10.1016/j.bbamem.2011.03.016","Membrane protein mimetic","Various transmembrane proteins, including EGF receptor, bacteriorhodopsin, magainin, protegrin, Influenza M2 channel, and others","Multilamellar Vesicles","Mimics cellular membranes with multiple lipid bilayers.","Suitable for solid-state NMR studies, providing a concentrated lipid environment for embedded proteins."
"2011","https://doi.org/10.1016/j.cbpa.2011.02.015","b-hairpin mimetics","LptD (outer membrane protein)","","Targets outer membrane biogenesis","Inhibits LPS transport to the outer membrane"
"2011","https://doi.org/10.4049/jimmunol.1002847","Peptide Mimetic","Apolipoprotein E (apoE)","COG1410","Immunomodulatory","Reduces TNF-a production; activates PP2A; inhibits NF-kB pathway; enhances PP2A activity in vivo."
"2011","https://doi.org/10.4049/jimmunol.1002847","Peptide Mimetic","Apolipoprotein E (apoE)","COG112","Immunomodulatory","Reduces activation of the NF-kB pathway; inhibits inflammatory responses."
"2011","https://doi.org/10.4049/jimmunol.1002847","Peptide Mimetic","Apolipoprotein E (apoE)","apoE[133–149]","Immunomodulatory","uppresses microglial activation and inflammatory mediator secretion (e.g., TNF-a and IL-6); reduces serum TNF-a and IL-6 production in mice treated with LPS."
"2011","https://doi.org/10.1016/j.drup.2007.08.002","small-molecule BH3 mimetics","BH3","HA14-1","Targets leukemia, myeloma, glioblastoma, prostate cancer","Inhibits Bcl-2"
"2011","https://doi.org/10.1016/j.drup.2007.08.002","small-molecule BH3 mimetics","BH3","BH3-Is","Targets leukemia, prostate cancer, non-small cell lung cancer","Inhibits Bcl-XL"
"2011","https://doi.org/10.1016/j.drup.2007.08.002","small-molecule BH3 mimetics","BH3","Antimycin A","Targets leukemia and cervical cancer","Inhibits Bcl-2, Bcl-XL"
"2011","https://doi.org/10.1016/j.drup.2007.08.002","small-molecule BH3 mimetics","BH3","Gossypol","Targets leukemia, lymphoma, glioblastoma, prostate cancer","Inhibits Bcl-2, Bcl-XL, Mcl-1"
"2011","https://doi.org/10.1016/j.drup.2007.08.002","small-molecule BH3 mimetics","BH3","Apogossypol","Targets leukemia, lymphoma, glioblastoma, prostate cancer","Inhibits Bcl-2, Bcl-XL, Mcl-1"
"2011","https://doi.org/10.1016/j.drup.2007.08.002","small-molecule BH3 mimetics","BH3","TW-37","Targets leukemia, lymphoma, glioblastoma, prostate cancer","Inhibits Bcl-2, Bcl-XL, Mcl-1"
"2011","https://doi.org/10.1016/j.drup.2007.08.002","small-molecule BH3 mimetics","BH3","GX015-070","Targets leukemia, lymphoma, myeloma, lung cancer","Inhibits Bcl-2, Bcl-XL, Mcl-1"
"2011","https://doi.org/10.1016/j.drup.2007.08.002","small-molecule BH3 mimetics","BH3","ABT-737","Targets leukemia, lymphoma, lung cancer, breast cancer","Inhibits Bcl-2, Bcl-XL, Bcl-w"
"2011","https://doi.org/10.1021/jm101651b","Bivalent","smac","(S,3S,3′S,6S,6′S,10aS,10a′S)-N,N′-((1S,1′S)-(1,1′-(1,4- phenylenebis(methylene))bis(1H-1,2,3-triazole-4,1- diyl))bis(phenylmethylene))bis(6-((S)-2-(methylamino)propanamido)-5- oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide)","Induces degradation of cIAP2","Fails to induce caspase-3 processing at 30 nM"
"2011","https://doi.org/10.1021/jm101651b","Bivalent","smac","(S,3S,3′S,6S,6′S,10aS,10a′S)-N,N′-((1S,1′S)-(1,1′-(1,4-phenylenebis(ethane-2,1- diyl))bis(1H-1,2,3-triazole-4,1-diyl))bis(phenylmethylene))bis(6-((S)-2- (methylamino)propanamido)-5-oxodecahydropyrrolo[1,2-a]azocine-3- carboxamide)","Induces degradation of cIAP1/2","Limited effect on cIAP1 degradation at 30 nM"
"2011","https://doi.org/10.1021/jm101651b","Bivalent","smac","(S,3S,3′S,6S,6′S,10aS,10a′S)-N,N′-((1S,1′S)-(1,1′-(1,4- phenylenebis(propane-3,1-diyl))bis(1H-1,2,3-triazole-4,1- diyl))bis(phenylmethylene))bis(6-((S)-2-(methylamino)propanamido)-5- oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide)","Induces degradation of cIAP1","Induces PARP cleavage and caspase-3 processing"
"2011","https://doi.org/10.1021/jm101651b","Bivalent","smac","(S,3S,3′S,6S,6′S,10aS,10a′S)-N,N′-((1S,1′S)-(1,1′-(1,4-phenylenebis(hexane-6,1-\ndiyl))bis(1H-1,2,3-triazole-4,1-diyl))bis(phenylmethylene))bis(6-((S)-2-\n(methylamino)propanamido)-5-oxodecahydropyrrolo[1,2-a]azocine-3-\ncarboxamide)","Induces degradation of cIAP1/2","Robust activity at low concentrations"
"2011","https://doi.org/10.1021/jm101651b","Bivalent","smac","(S,3S,3′S,6S,6′S,10aS,10a′S)-N,N′-((1S,1′S)-(1,1′-(oxybis(pentane-5,1- diyl))bis(1H-1,2,3-triazole-4,1-diyl))bis(phenylmethylene))bis(6-((S)-2- (methylamino)propanamido)-5-oxodecahydropyrrolo[1,2-a]azocine-3- carboxamide)","Antagonist of IAPs","Completely inhibits tumor growth in MDA-MB-231 xenografts"
"2011","https://doi.org/10.1517/14728222.2011.640319","peptide","TSP1","ABT-510","anti-angiogenic at low nanomolar concentrations,  promising, but compromised by its short half life","blocks angiogenesis and cancer progression in multiple preclinical models"
"2011","https://doi.org/10.1517/14728222.2011.640319","peptide","TSP1","ABT-526","potent anti-angiogenic activity and clearance sufficient to allow testing in pre-clinical tumor models.","Because of its slower clearance in primates, and higher water solubility the D-alloIle peptide, ABT-510 was chosen over its enantiomer, ABT-526, for human trials."
"2011","https://doi.org/10.1517/14728222.2011.640319","peptide","TSP1","ABT-898","more stable and more potent","active in the preclinical models of cancer, inflammatory disease and eye disease"
"2011","https://doi.org/10.1016/j.ijmm.2010.04.020","synthetic heme– protein","peroxidase","FeIII–mimochrome VI,","catalytic efficiency is comparable to that of native\nhorseradish peroxidase","By the use of hydrogen peroxide, FeIII–mimochrome VI efficiently catalyzes the oxidation of several substrates, with a typical Michaelis–Menten mechanism and with several multiple turnovers , converts\nphenol to 4- and 2-nitrophenol in the\npresence of NO2\n and H2O2 in high\nyields. T"
